Serina Therapeutics, Inc. (SER) SEC Filings — 2024

Filings

• Serina Therapeutics Files 8-K on Definitive Agreement & Asset Deal — 8-K · Dec 26, 2024
• Serina Therapeutics Files 8-K on Officer/Director Changes & Shareholder Votes — 8-K · Dec 18, 2024
• Serina Therapeutics Files 8-K — 8-K · Dec 11, 2024
• Juvenescence Ltd Amends Serina Therapeutics Stake — SC 13D/A · Dec 9, 2024
• Serina Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 2, 2024
• Serina Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Serina Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
• Serina Therapeutics Files 8-K on Financials — 8-K · Nov 12, 2024
• Serina Therapeutics Files Definitive Proxy Statement — DEF 14A · Nov 6, 2024
• Serina Therapeutics Files 8-K — 8-K · Oct 2, 2024
• Serina Therapeutics: Director Departs, CMO Appointed — 8-K · Sep 12, 2024
• Serina Therapeutics Files 8-K with Regulatory Updates — 8-K · Sep 5, 2024
• Serina Therapeutics Announces Board and Executive Changes — 8-K · Aug 16, 2024
• Serina Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 9, 2024
• Serina Therapeutics Files 8-K — 8-K · Jul 29, 2024
• Serina Therapeutics Appoints New CMO, Director — 8-K · Jul 18, 2024
• Serina Therapeutics Appoints New CMO, Director — 8-K · Jul 12, 2024
• Juvenescence Ltd Files 13D/A Amendment for Serina Therapeutics — SC 13D/A · Jul 5, 2024
• Serina Therapeutics Files S-1/A, Reports $1.45M Cash — S-1/A · Jul 3, 2024
• Serina Therapeutics Files S-1/A with Financial Updates — S-1/A · Jun 17, 2024
• Serina Therapeutics Files 8-K for Other Event — 8-K · Jun 10, 2024
• Serina Therapeutics Files 8-K on Financials — 8-K · May 14, 2024
• Serina Therapeutics Changes Principal Accounting Firm — 8-K · May 3, 2024
• Serina Therapeutics Appoints New Directors, CEO Compensation Change — 8-K · Apr 17, 2024
• Randall Moreadith Files SC 13D for Serina Therapeutics — SC 13D · Apr 3, 2024
• AgeX Therapeutics Acquired by 03 Life Sciences — 8-K · Apr 1, 2024
• Juvenescence Ltd Amends AgeX Therapeutics Stake — SC 13D/A · Mar 26, 2024
• AgeX Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 22, 2024
• AgeX Therapeutics Files 8-K: Stockholder Meeting, Bylaw Changes — 8-K · Mar 14, 2024
• Juvenescence Ltd Amends AgeX Therapeutics Stake Filing — SC 13D/A · Mar 7, 2024
• AgeX Therapeutics Secures Up to $20M Loan — 8-K · Mar 7, 2024
• Juvenescence Ltd Amends AgeX Therapeutics Ownership Filing — SC 13D/A · Feb 14, 2024
• AgeX Therapeutics Enters Material Agreement, New Financial Obligation — 8-K · Feb 14, 2024
• AgeX Therapeutics Reports Merger-Related Financial Obligations, Equity Sales — 8-K · Feb 6, 2024
• Juvenescence Ltd. Files 31st Amendment to AgeX Therapeutics Stake — SC 13D/A · Feb 5, 2024
• AgeX Therapeutics Reports New Direct Financial Obligation — 8-K · Jan 19, 2024
• Juvenescence Amends AgeX Therapeutics Stake (Amendment No. 30) — SC 13D/A · Jan 17, 2024
• AgeX Therapeutics Reports Executive/Director Changes, Comp. Arrangements — 8-K · Jan 11, 2024
• Juvenescence Ltd. Amends AgeX Therapeutics Stake (Amendment 29) — SC 13D/A · Jan 9, 2024
• AgeX Therapeutics Reports New Direct Financial Obligation — 8-K · Jan 5, 2024